EXECUTIVE ENGAGEMENTS
POOL
1623
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
293
Interactions with Platform & by Email
PARTICIPANTS
63
Unique # Participated
VALIDATIONS
13
Responses Validated*
COMPANIES
24
Responses Validated*
* Login for a full stack data experience
DATE
JAN 2022
TABLES
123
PAGES
183
EDITION
8
PRICE
USD 4950
CODE
MCP12453
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Human Microbiome estimated at US$391 Million in the year 2020, is projected to reach a revised size of US$964.5 Million by 2027, growing at a CAGR of 13.8% over the analysis period 2020-2027. Acute Diarrhea, one of the segments analyzed in the report, is projected to record a 14.9% CAGR and reach US$527 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Obesity segment is readjusted to a revised 12.6% CAGR for the next 7-year period.
The Human Microbiome market in the U.S. is estimated at US$115.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$167.2 Million by the year 2027 trailing a CAGR of 13.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.2% and 11.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR.
In the global Diabetes segment, USA, Canada, Japan, China and Europe will drive the 13.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$12 Million in the year 2020 will reach a projected size of US$29.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$114.2 Million by the year 2027.
SELECT PLAYERS
DowDuPont, Inc.; Enterome SA; Merck & Co., Inc.; Metabiomics Corporation; Microbiome Therapeutics, LLC.; Osel, Inc.; Second Genome; Vedanta Biosciences, Inc.; ViThera Pharmaceuticals, Inc.; Yakult Honsha Co., Ltd.
SEGMENTS
» Application (Therapeutics, Diagnostics) » Disease Indication (Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, Other Diseases) » Product Type (Probiotics, Prebiotics, Foods, Medical Foods, Drugs, Other Product Types)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Human Microbiome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Human Microbiome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Human Microbiome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Acute Diarrhea by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Acute Diarrhea by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Acute Diarrhea by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Obesity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Autoimmune Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Mental Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Mental Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Mental Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Other Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Probiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Prebiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Prebiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Prebiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Foods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Medical Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Medical Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Medical Foods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| World Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| USA Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| USA 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
| USA Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| USA Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| USA 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
| USA Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| USA Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| USA 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Canada Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Canada 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
| Canada Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Canada Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Canada 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
| Canada Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Canada Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Canada 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Japan Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Japan 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
| Japan Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Japan Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Japan 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
| Japan Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Japan Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Japan 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
| CHINA |
| China Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| China Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| China 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
| China Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| China Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| China 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
| China Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| China Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| China 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Human Microbiome by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
| Europe Historic Review for Human Microbiome by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Europe 15-Year Perspective for Human Microbiome by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2018 & 2027 |
| Europe Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Europe Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Europe 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
| Europe Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Europe Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Europe 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
| Europe Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Europe Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Europe 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
| FRANCE |
| France Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| France Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| France 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
| France Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| France Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| France 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
| France Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| France Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| France 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Germany Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Germany 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
| Germany Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Germany Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Germany 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
| Germany Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Germany Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Germany 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Italy Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Italy 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
| Italy Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Italy Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Italy 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
| Italy Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Italy Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Italy 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| UK Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| UK 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
| UK Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| UK Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| UK 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
| UK Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| UK Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| UK 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Rest of Europe Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Rest of Europe 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
| Rest of Europe Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Rest of Europe Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Rest of Europe 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
| Rest of Europe Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Rest of Europe Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Rest of Europe 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Asia-Pacific 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
| Asia-Pacific Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Asia-Pacific 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
| Asia-Pacific Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Asia-Pacific 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Rest of World Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Rest of World 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
| Rest of World Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Rest of World Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Rest of World 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
| Rest of World Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
| Rest of World Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
| Rest of World 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 24 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com